SGBIライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (18 1月 2024 @ 04:24):

Stats
本日の出来高	200 000
平均出来高	0.00
時価総額	314 853
EPS	$-0.000390 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00100 (66.67%)

Insider Trading

Date	Person	Action	Amount	type
2022-06-30	Striepe Thomas	Sell	0	Common Stock
2022-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-10-13	Schmelz Hubertus	Buy	1 200 000	Common Stock
2021-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-06-30	Striepe Thomas	Sell	0	Common Stock

INSIDER POWER
0.00
Last 82 transactions
Buy: 3 836 313 \| Sell: 156 955

ボリューム相関

長: -0.01 (neutral)

短: 0.00 (neutral)

Signal:(41.164) Neutral

Sangui Biotech 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Sangui Biotech 相関 - 通貨/商品

0.86
( strong )

0.88
( strong )

0.00
( neutral )

-0.85
( strong negative )

Sangui Biotech 財務諸表

Annual	2023
収益:	$93 039.00
総利益:	$93 039.00 (100.00 %)
EPS:	$-0.000700

FY	2023
収益:	$93 039.00
総利益:	$93 039.00 (100.00 %)
EPS:	$-0.000700

FY	2022
収益:	$69 190.00
総利益:	$69 190.00 (100.00 %)
EPS:	$0.000100

FY	2021
収益:	$65 585.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.000974

Financial Reports:

No articles found.

Sangui Biotech

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.